𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Clinical Trials in Breast Cancer

✍ Scribed by Klauber-DeMore, Nancy; Boolbol, Susan K.; Derossis, Anna M.; Ruo, Leyo; Bernik, Stephanie F.; Borgen, Patrick I.

Book ID
122464577
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
216 KB
Volume
11
Category
Article
ISSN
1055-3207

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized Clinical Trials in Breast Can
Randomized Clinical Trials in Breast Cancer
✍ Crago, Aimee M.; Azu, Michelle; Tierney, Shannon; Morrow, Monica πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 173 KB
Randomized clinical trial of CFP versus
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer
✍ Robert F. Marschke JR.; James N. Ingle; Daniel J. Schaid; James E. Krook; James πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 644 KB

A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and C M F P (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone). Both r

Reasons for non-entry in randomized clin
Reasons for non-entry in randomized clinical trials for breast cancer: A single institutional study
✍ Dr. Cyrus A. Kotwall; Leo J. Mahoney; Robert E. Myers; Linda Decoste πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 440 KB

## Abstract Reasons for patient non‐entry in randomized clinical trials (RCTs) assessing oncologic treatment modalities are not well documented in the literature. We have prospectively recorded reasons for RCT non‐entry in breast cancer patients at St. Michael's Hospital, Toronto. From September 19